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Abstract
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Objective: Links between secondhand smoke (SHS) exposure and cardiovascular disease in
adults are well established but seldom reported during childhood. Although rates of smoking have
decreased, young children from low-income backgrounds remain likely to be exposed to SHS. The
purpose of this study was to investigate relationships between SHS exposure in young children and
several preclinical markers of cardiovascular risk that have been established as relevant to adult
populations.
Methods: 139 children, 2–5 years of age, were enrolled in a cross-sectional study. SHS exposure
was objectively determined by hair nicotine level; a comprehensive panel of clinical markers (AM
blood pressure, fasting glucose & insulin, lipid profiles, inflammation) and research markers
(markers of oxidation, endothelial stress, and endothelial repair) of cardiovascular risk status were
assessed. Univariate and multivariate linear regression were used to evaluate relationships between
SHS exposure and cardiovascular risk markers.
Results: Hair nicotine levels were directly correlated with blood pressure and serum CRP, and
inversely correlated with serum HDL and endothelial cell progenitor cell prevalence. In
multivariate analyses, these relationships remained when controlled for age, sex, BMI z-score,
maternal education, and method of payment. Additionally, in multivariate analyses, hair nicotine
level was significantly negatively correlated with total anti-oxidant capacity.
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Conclusions: These results support the view that SHS exposure in the very young has a
detectable relationship with several markers of cardiovascular risk, long before the emergence of
clinical disease. Further studies to define mechanisms and strategies to prevent and mitigate these
risks early in life are warranted.

Address Correspondence to: Judith A Groner MD, Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, Ohio, 43205.
Phone: 614-722-4957, Fax: 614-722-4966, Judith.groner@nationwidechildrens.org.
Conflict of Interest Statement: We have no conflict of interest to disclose.

Groner et al.

Page 2

Author Manuscript

BACKGROUND:
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The latest CDC report shows that despite an overall reduction in secondhand smoke (SHS)
exposure from 1999 to 2015, 25% of the US population remains exposed1. Of special
concern are children from low-income homes and African-American children, since they
have the highest rates of biologically measured SHS exposure1. Over 40% of US children
aged 3–11 were exposed to tobacco smoke from 2011–2012, based on a biological marker of
exposure, serum cotinine levels1. An inverse relationship between socioeconomic status and
SHS exposure has been well documented2, 3, and recent analyses have shown that for every
decrease in family income ratio, serum cotinine levels increased by 1.18 ng/L among
children2. This evidence, coupled with a burden of lifetime exposure make young children of
utmost concern. Better defining health risks of SHS in young children from low-income
settings may help to underscore this health-risk disparity and help pediatricians to enhance
strategies to mitigate these risks.
Links between SHS and cardiovascular disease (CVD) and death in adults are very well
established4–7. SHS is a known risk factor for the development of atherosclerotic heart
disease and increases the risk of CVD by about 30% in non-smoking adults5–7. In contrast to
compelling evidence in adults studies demonstrating cardiovascular implications of SHS
exposure during childhood are less defined. Young children are at particular risk for SHS
exposure2, 8. More importantly, in our previous work, we demonstrated that toddlers had
higher hair nicotine levels when compared to older children with equivalent survey measures
of SHS exposure9.
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A challenge for studying cardiovascular risk in pre-adulthood is the fact that children and
adolescents very rarely exhibit clinical manifestations of acquired (non-congenital) heart
disease. Most adult forms of cardiovascular disease are either related to or driven by
inflammatory processes4, and such processes are apparently initiated in childhood. However,
few studies have assessed the concurrent relationship between SHS exposure and
cardiovascular risk markers in children younger than six years old10.
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Our goal was to better define the relationship between SHS exposure in toddlers age 2–5 and
preclinical cardiovascular disease risk. We investigated several surrogate markers of CVD
risks in relation to SHS exposure and included traditional clinical measures as well as
research measures recognized as relevant and mechanistically involved in adult settings.
Clinical measures were blood pressure, glucose metabolism, blood lipids, and markers of
inflammation, while ‘research measures’ were markers oxidation, and vascular endothelial
stress and endothelial repair. Each of these indicators has been linked to SHS exposure and
cardiovascular disease in adult or older pediatric populations7, 11–14 but has not been
investigated in very young children. Prior studies have not focused on this age group where
cardiovascular implications of SHS may be importantly under-recognized.
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METHODS:
Human Subject Recruitment:
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The Nationwide Children’s Hospital (NCH) IRB approved of the study. Participants were
children aged 2–5 years and parents provided informed consent. They were recruited via
convenience sampling through recruiting in Nationwide Children’s Hospital Primary Care
Network (Columbus, Ohio), and advertising via an internal hospital e-mail system. The
Primary Care Network primarily serves low-income, urban children in Columbus. Inclusion
criteria were healthy children both exposed and unexposed to SHS by parental report.
Exclusion criteria were: the presence of one or more of the following: acute febrile illness or
other active infections, congenital heart disease, diabetes (Type 1 or 2), elevated fasting
glucose (>100 mg/dl), family history of elevated cholesterol, use of oral or inhaled (antiinflammatory) steroids within one month of testing, and/or not having enough hair for hair
sampling of SHS exposure (hair nicotine level). This approach to enrollment thus avoided
children with persistent asthma, because of the use of daily anti-inflammatories, which we
considered confounding for this present study.
Study Procedures:

Author Manuscript

The study was introduced to the mother or caregiver at a clinic visit. Subjects were
subsequently scheduled for testing at a research site in the morning between 8–10am, after
overnight fasting. The protocol was carried out as follows: a) Study procedures were
described with parental informed consent and youth/teen assent and consent obtained, b)
anthropomorphic measurements obtained, c) structured interview with subject and parent
(demographics and SHS exposure history), d) hair sample obtained and e) the blood sample
of 7 ml was collected for biomarkers and covariates. After serum sample collection all
assays were stored on ice and used within 12hrs of collection (24hr for flow cytometry
studies).
Height, Weight, BMI:
Height and weight were obtained using a Tanita BWB800 scale and Seca stadiometer.
Heights were measured to the nearest 0.5cm, weights to the nearest 0.1kg. BMI’s and zscore norms were determined according to CDC guidelines (http://www.cdc.gov/
healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.htmlref).
Measured variables:
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We assessed a comprehensive panel of clinically relevant and research-based outcome
variables that have been used by others to reflect cardiovascular status and related disease
risks. Brief descriptions of methods and rationale are shown below. Additional analytical
details are provided in online supplemental materials.
Secondhand smoke exposure:
Hair nicotine was used as a biological marker of SHS exposure to assess long-term
evaluation of smoke exposure since the nicotine is incorporated into the growing hair shaft
over several months. Samples are easy to obtain, handle, and store. Approximately 20–40
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hair shafts from the occipital area were cut at the root and 2–3 cm in length. Hairs were
stored and later sent for assay at an established contract research facility (Johns Hopkins
School of Public Health). The hair nicotine assay involves washing the hair sample before
analysis and therefore is designed to measure inhaled nicotine, and not ambient nicotine
simply adhered to hair. Content is expressed as ng/mg of hair.
Blood pressure:
Blood pressure was measured via a Critikon-Dinamap Compact T monitor. The subject was
fasting and allowed upright (typically in a parent’s lap) for at least 5 minutes, the
measurement is taken on the subject’s left arm while. Normalized BP (percentile of
normative values) was derived from NHLBI tables, accounting for height, age, and gender
(http://www.nhlbi.nih.gov/guidelines/hypertension/child_tbl.htm).
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Blood lipid profiles, glucose, insulin:
Fasting lipid profiles and glucose were measured via our hospital core lab facility. Insulin
was determined by EIA (GenWay Biotech Inc. San Diego, CA, Cat# 40-056-205011).
Biomarkers of inflammation:

Author Manuscript

C-reactive protein (CRP): This was measured as a classical and clinically relevant
measure of systemic inflammation that has been linked to SHS exposure in both adults and
children11, 15. Elevations in serum CRP, and increased gene expression in the myocardium,
have also been demonstrated in many forms of adult heart disease and is a strong
independent predictor of CVD risk in adults16. This was measured using a commercially
available enzyme immunoassay test kit (BioCheck, Inc, Foster City, CA; Cat # BC-1119).
Intra- and inter- assay variations are less than 5 and 11%, respectively.
Serum IL-6 and TNF: These cytokines were measured as research-based markers of
systemic inflammation. Both IL-6 and TNFα have been correlated with adiposity in children
6–19 years of age. Association of these markers with SHS is less known, especially in young
children. Plasma IL-6 levels were determined using a highly sensitive ELISA kit (R&D
systems, Minneapolis, MN; Cat # DY206). Intra and inter- assay variations are less than 8
and 10%, respectively.
Biomarkers of oxidation:
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Protein malondialdehyde adducts: This is a measure of lipid peroxidation in serum17.
Malondialdehyde is a highly reactive three-carbon dialdehyde byproduct of fatty acid
peroxidation, which readily combines with several functional groups on molecules including
proteins. We have found significant relationships between protein MDA and hair nicotine
level in obese teenagers18. These were measured by OxiSelect™ MDA Adduct competitive
ELISA kits from Cell Biolabs, INC, San Diego, CA (Cat#STA-832–5). The quantity of
MDA adduct in samples was determined by comparing its absorbance with that of a
predetermined MDA-BSA standard curve, and reported as pmol MDA/mL.
Total plasma anti-oxidant capacity: This measurement provides a non-specific
measure of ‘antioxidant reserve’ in plasma and is thus an indication of the overall capability
J Pediatr. Author manuscript; available in PMC 2019 April 03.
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to counteract reactive oxidizing species and combat oxidative stress related diseases. It has
been shown to be reduced in many settings of chronic inflammation/oxidation19. Both small
molecule and protein antioxidants are measured in aggregate, and results are presented as
mM Trolox equivalents (a reference reagent with quantitative antioxidant capacity).
Commercial assay kits were from Biovision Research Products (Cat#K274–100), Mountain
View, CA. Cu++ was converted to Cu+ by both small molecules and protein antioxidants in
plasma samples. The levels of reduced Cu+ ion were determined by the absorbance of a
chelated colorimetric probe. Trolox was used as a standard antioxidant and total plasma
antioxidant capacity was expressed as mM Trolox equivalents.
Biomarkers of vascular endothelial stress:
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Soluble intercellular adhesion molecule-1 (s-ICAM1) was measured as a biomarker of
endothelial stress and activation. Elevations in this marker have been documented in several
settings of vascular injury (including coronary heart disease), and in relation to SHS
exposure.13 Levels of s-ICAM-1 were determined using a sensitive commercially available
ELISA kit (R&D systems, Minneapolis, MN; Cat # DY720). Intra and inter- assay variations
are less than 5 and 10%, respectively.
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Circulating endothelial progenitor cells (EPCs): EPCs are bone marrow–derived
stem cells that have the ability to differentiate into functional endothelial cells, circulate in
the blood and home preferentially to sites of vascular or tissue injury, contributing
significantly to both endothelial repopulation and neovascularization20. These cells have
been recognized as a potential surrogate biological marker for vascular function and
cumulative cardiovascular risk in adults21, 22. Decreased EPC number and function have
been shown in adult non-smokers exposed to SHS23 but have not been studied in
relationship to SHS exposure in young children.
A volume of 50μL anticoagulated peripheral blood was incubated with 50μL 3% BSA in
PBS (without Ca++ and Mg++) at room temperature for 30 min. In dark, fluorescence labeled
antibodies (2.5μL of each), PE-CD133, FITC-CD34, and PECy5-CD45, were added and
incubated for 30 min at room temperature. FACS lysis buffer (450μL) was then added, and
incubated for 30min at room temperature in dark. Samples were then analyzed on FACS
Caliber flow cytometer, where total counts were >400,000 cells. Prevalence of CD34+/
CD45-, CD133+/CD45-, or CD34+/CD133+/CD45- cells was expressed as the percentage
of total events.
Statistical analyses:
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Statistical analyses were performed with Stata 13.1 (StataCorp. 2013 Stata Statistical
Software: Release 13.0; Stata Corporation, College Station, TX). A P value of 0.05 or less
was considered statistically significant. Categorical variables were used to indicate sex
(female=1, male=0); race (African American, White, Biracial, and Other Race); ethnicity
(Hispanic or Latino=1, Non-Hispanic=0), insurance status (Medicaid benefits=1, All other
insurance=0); maternal education (less than high school, high school graduate or GED, some
college, or college graduate or higher).
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Continuous outcome variables were used for child’s systolic blood pressure, diastolic blood
pressure, systolic blood pressure %, diastolic blood pressure %, total cholesterol, LDL,
HDL, fasting glucose, fasting insulin, CRP, IL-6, TNF-α, plasma protein malondialdehyde,
total anti-oxidant capacity, soluble iCAM-1, and EPC prevalence. In multivariate regression
analysis, fasting insulin, CRP levels, Il-6, TNF-α, plasma protein malondialdehyde and EPC
prevalence were logarithmically transformed to improve the distribution of these variables.
Age and BMI were also modeled as continuous measures. BMI was converted to a BMI zscore. A program available in Stata, zscore06 was used to calculate anthropometric z-scores.
Length/height for-for-age, weight-for-height, BMI-for-age and weight-for-age Z-scores were
calculated.
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Bivariate associations between baseline demographic characteristics, SHS, and all
cardiovascular outcomes were examined first using Pearson correlations. Multivariate linear
regression with robust standard errors, clustered on family ID to account for the clustering of
children within the same family was used to model each of the cardiovascular outcomes
separately. All models included covariates for sex, race, ethnicity, insurance status, maternal
education, age, and BMI z-score. Descriptive statistics are presented for all variables (means
and SD for normally distributed and medians and interquartile ranges for skewed variables).
Only significant models are presented for the multivariate models. Among the 149 children
2–5 years of age that were included in the study, 10 had missing information on maternal
education, with a final sample size n=139Additionally, eight children had missing
information on systolic blood pressure, and systolic blood pressure % and 9 had missing
values for EPC prevalence. The models for CRP and TAC each had one additional missing
case. Since models were run separately by outcome, the final sample size for blood pressure
was n=131, TAC n=138, CRP n=138 and for EPC n=122. All other models presented had
the full sample, minus those missing maternal education, n=139. Sensitivity analysis has
confirmed that there are no significant differences with or without missing cases.
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RESULTS:
Population characteristics and sample distributions:
Characteristics of the study subjects are shown in Table 1. The average age was 3.2 yrs, and
the majority (82%) was of lower socioeconomic status (insured through Medicaid), with a
minority of mothers having a college degree or higher (14%). One-third of the group was
either overweight (10.7%) or obese (22.8%).
Secondhand smoke exposure and hair nicotine levels:
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The enrolled participants were highly smoke exposed (Table 1); 66.4% subjects lived with a
smoker, and forty (26.8%) lived with 2 or more smokers. Maternal smoking was present in
sixty-two (42.3%) of the enrolled subjects. Hair nicotine levels were not normally
distributed, the median was 1.86ng/mg, with an average hair nicotine of 5.51 ng/mg (SD
8.43), and a wide range of exposure levels from 0.03 ng/mg (virtually no exposure) to 39.45
ng/mg.
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Table 2 presents the results of all outcome variables analyzed. Means and standard
deviations are presented for the normally distributed variables, medians and interquartile
ratios are presented for the variables with skewed distributions.
Simple bivariate analyses: SHS vs. other measured cardiovascular risk variables.
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Preliminary bivariate analyses were performed using Pearson correlations, examining the
associations between log-transformed hair nicotine vs. each other demographic and other
measured variables (n=131–139 for each pairwise analysis). Log hair nicotine was
significantly positively related to SBP (Pearson’s r= 0.21), SBP% (Pearson’s r= 0.30), and
DPB (Pearson’s r=0.17), all significant at < 0.05. Additionally, log hair nicotine was
inversely related to total cholesterol (Pearson’s r = −0.23) and HDL cholesterol (Pearson’s r
= −0.23); both significant at the < 0.05 level. Log hair nicotine was significantly positively
related to log CRP (Pearson’s r = 0.21), and negatively related to EPC prevalence (Pearson’s
r = −28), both significant at the 0.05 level. There was no significant relationship between log
hair nicotine and diastolic blood pressure percent, triglycerides, LDL and VLDL cholesterol,
fasting glucose or insulin levels, IL6, TNFα, MDA, TAC, and s-ICAM1.
Multivariate regression analyses:
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Separate multivariate linear regression analysis (clustered on family ID with robust standard
errors) examined the relationship between log-transformed hair nicotine and all
cardiovascular outcomes above. All models included controls for sex, age, race, ethnicity,
method of payment, maternal education, and BMI z-score (Table 3). Log hair nicotine was
independently significantly related to systolic blood pressure, systolic blood pressure
percentile, HDL, CRP, TAC, and EPC prevalence. BMI z-score was also independently
related to systolic blood pressure, systolic blood pressure percent, and HDL; however, no
interaction effect was found between BMI and hair nicotine for any of the cardiovascular
risk measures. Examining the clinical variables, each single log-increase in hair nicotine
(corresponding to 2.72 ng/mg hair) was associated with an increase of 4.68 mm/Hg for
systolic blood pressure, a 0.92 mg/L increase in CRP, and a 4.42 mg/dl decrease in HDL.
Regarding the research variables, each log-increase of hair nicotine was associated with a
decrease of 0.68 units for EPC prevalence and 6.872 units (mM Trolox equivalents) in total
anti-oxidant capacity.

DISCUSSION:
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Although SHS is now recognized as a significant contributor to cardiovascular risks in older
age groups, the toddler population has not been studied. The characteristics of the children
we enrolled match a population of very high concern for SHS exposure (urban, African
American, low-income)24. More than half of the study participants lived with one or more
smokers, and many of the participants had hair nicotine levels equivalent to published values
associated with adult active smokers. This subgroup of US children is of very high concern
regarding SHS exposure and later tobacco consumption and related disease risks.
In the present study, we evaluated an array of cardiovascular risk markers that encompassed
clinical measures (blood pressure, lipids, glucose metabolism, inflammation) as well as three
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recognized aspects of tobacco-related mechanisms of injury in adults, ‘research measures’ (oxidation, vascular endothelial injury, and vascular repair). The apparently healthy toddler
cohort had a wide range of values in these biomarkers. SHS exposure was independently
linked to higher systolic blood pressure, HDL reduction, CRP elevation (a marker of
inflammation), TAC reduction (a marker of oxidation) and EPC reduction (a marker of
vascular repair). These relationships are all mechanistically relevant and apparently
occurring simultaneously at a very young age. To our knowledge, this is one of the first
studies to investigate the link between SHS exposure and cardiovascular disease risk in
toddlers. These data extend prior work on the cardiovascular effects of tobacco exposure to a
younger age group than previously studied.
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Our findings demonstrate that health disparities noted during adulthood may at least be
partially accounted for by early life SHS exposure. Epidemiological studies have shown the
association between low socio-economic status during childhood and increased
cardiovascular morbidity and mortality during adult life25. The lifetime health burden of
youth who are SHS-exposed is bound to be significant. For example, a recent analysis of the
Bogalusa Heart Study has shown that SHS exposure during childhood only showed a
stronger association with cardiovascular risk than exposure in adulthood only26, suggesting
an ‘imprinting effect’ of SHS-related disease risks. In addition to cumulative effects of years
of exposure, children who grow up with smokers also are at greater risk of becoming active
smokers due to the parental modeling of smoking behavior27. Obesity prevalence also varies
inversely with SES28, and we noted an independent relationship between BMI z-score and
systolic blood pressure and lower HDL among this group. Our goal should be to enhance our
identification of the most-at-risk children and develop effective strategies to intervene and
prevent adult cardiovascular disease.
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One strength of this study is the focus on highly exposed, low-income, city-dwelling,
children that may be the most vulnerable to physiological perturbations of SHS exposure. A
convenience sample rather that a random or epidemiologically based sample is a potential
limitation of this study, but we have no reason to believe that the relationships between SHS
and outcomes investigated would be different due to sampling technique. We controlled for
potential confounders including age, race, maternal education, method of payment, and BMI
z-score, and acknowledge that this was a cross-sectional study, from which we can infer
correlation but not causation. However, our findings are biologically plausible and align with
previous data from older children, teens, and adults.
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Another potential limitation is that we excluded children with persistent asthma. This
exclusion would have biased our findings toward the null by excluding children with the
most inflammation so that we may have underestimated the relationships between SHS and
inflammation. Studies to understand the complete picture of cardiopulmonary risks and
disease course patterns are needed, especially in young children.
In a very recent scientific statement, the American Heart Association has concluded that
SHS is a compelling threat to cardiovascular health in children and that current evidence
warrants “…a robust public health policy that embraces zero tolerance of childhood SHS
exposure.” Our study supports this view since we found an objectively measured marker of
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SHS (hair nicotine) was correlated to several variables already well-established as
cardiovascular risk markers in adults. The fact that these relationships have been detected in
toddlers, several decades before typical symptomatic heart disease, is alarming and may help
to catalyze actions to enhance protection of young children from tobacco-related disease
risks.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1:

Author Manuscript

Demographic data (n=139)
Subject Characteristics

Mean ± SD or N(%)

Age, years

3.22 ± 1.06

Female

76 (55%)

Race
African-American

76 (54.68%)

White

32 (23.02%)

Multi-racial

24 (17.27%)

Other

7 (5.03%)

Ethnicity

Author Manuscript

Hispanic or Latino

12 (8.63%)

Family Economic Status
Subject insured by Medicaid, n (%)

122 (82%)

Maternal Education, n (%)
Less than high school

44 (31.65%)

High school or GED

35 (25.18%)

Some college

41 (29.50%)

College graduate

19 (13.67%)
Mean ± SD or median (range)

Author Manuscript

SHS exposure: hair nicotine (ng/mg)

5.51 ± 8.43

Hair nicotine median, range (ng/mg)

1.86 (0.025 – 39.45)

BMI,

kg/m2

BMI, z-score

16.98 ± 2.28
0.90 ± 1.39

Author Manuscript
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Table 2.

Author Manuscript

Measured variables

Author Manuscript

Mean ± SD

Sample N

Systolic Blood Pressure, mm Hg

95.59 ± 10.53

131

Diastolic Blood Pressure, mm Hg

59.70 ± 8.21

131

Systolic Blood Pressure, %

59.77 ± 27.98

131

Diastolic Blood Pressure, %

74.83 ± 20.00

131

Total Cholesterol, mg/dL

146.46 ± 26.82

139

Low Density Lipoprotein, mg/dL

84.35 ± 23.58

139

High Density Lipoprotein, mg/dL,

48.73 ± 13.28

139

Fasting blood glucose, mg/dl

80.68 ± 7.28

139

Total anti-oxidant capacity, mm Trolox equivalent

102.59 ± 22.65

138

Soluble ICAM-1, ng/mL

206.89 ± 64.96

138

Normally distributed variables

Median (IQR)
Skewed distribution variables
Fasting insulin, uIU/mL

6.46 (5.33–8.33)

138

C-Reactive Protein, mg/L

0.22 (0.04–1.27)

138

Interleukin-6, ng/L

13.31 (4.69–113.70)

138

TNF-α, ng/L

148.66 (76.54–1026.86)

138

Plasma protein malondialdehyde, pmol MDA/mL

18.8 (15.1–22.8)

138

Circulating CD34+ Cells, % of total events

0.0086 (0.0042–0.0156)

122

Author Manuscript
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3.

Author Manuscript

Multivariate Linear Regression Analysis of Associations with Logarithmically Transformed Hair Nicotine
Levels
Log Hair Nicotine
Outcome

Model N

b

SE b

P

Systolic blood pressure

139

4.68

1.84

.013

Systolic blood pressure %

139

15.32

5.21

.004

CRP

138

0.92

0.35

.012

HDL

139

−4.42

1.82

.017

Total anti-oxidant capacity

138

−6.72

3.08

.032

EPC prevalence

122

−0.39

0.17

.028

Author Manuscript

Notes: Each row represents a separate regression model. Each regression model is adjusted for sex, age, race, ethnicity, insurance payment,
maternal education, and BMI z-score is clustered on family ID and robust standard errors.
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